Abstract:Abstract Background Protease-activated receptors (PARs) and their activating enzymes have been postulated to play a role in inflammatory bowel disease (IBD) pathogenesis, but the specific roles of PAR2 in disease initiation and progression remain unclear. PAR2 activation has both pro-proliferative and pro-migratory effects and could be involved with the restoration of the epithelial barrier following injury. We previously showed that PAR2 activation increases epithelial wound healing through ERK, PI3K, and JNK pathways. However, the role of Src kinase and RhoGTPases, which PAR2 also activates, is not known. Purpose We hypothesized that PAR-2 activation induces wound healing in intestinal epithelial cells through Src and Rac1 activity. Method Circular wounds were made in T84 colonic epithelial cell monolayers. Wounded monolayers were treated with the PAR2 activating peptide, 2-furoyl-LIGRLO (2fLI, 5 μM), or the inactive control reverse-sequence peptide, 2-furoyl-OLRGIL (2fO, 5 μM), and live-cell imaging was used to record wound healing over a 24-hr period. Proliferation and apoptosis were measured using EdU and TUNEL assays, respectively. The mechanism of action was evaluated using inhibitors of Src (PP2), EGFR (PD153035), MLCK (ML-7), ROCK (Y-27632), Rac1 (NSC 23766), and Cdc42 (ML141), and western blot (WB) was used to confirm the protein levels of p-Src (Y416), p-ERK1/2, p-JNK, and p-PI3K. For immunofluorescence, images of E-cadherin and F-actin were taken to capture the entire wound border and surrounding cells. Result(s) PAR2 activation by 2fLI promoted wound healing compared to 2fO or vehicle control at the 24-hr time point (p<0.05). PAR2 activation had no effect on proliferation at the wound edge and did not affect apoptosis but did enhance lamellipodia/filopodia formation (p<0.001). These findings indicate that PAR2 reprograms the cells toward a migratory rather than a proliferative phenotype. When we investigated the mechanisms of action, the Src tyrosine kinase inhibitor, PP2, blocked PAR2-induced wound healing (p<0.0001). PAR2 activation increased Src phosphorylation (Y416, p<0.05) and the immunofluorescence showed a rise in actin cable formation at the wound edge and a reduction in lamellipodia/filopodia formation in the group treated with PP2 when compared to 2fLI (p<0.001). Although PAR2 activation increases the phosphorylation of ERK1/2 and JNK, this did not happen through Src. Furthermore, PAR2 did not increase the phosphorylation of PI3K as confirmed by WB analysis. Inhibition of EGFR (PD153035), MLCK (ML-7), ROCK (Y-27632), and Cdc42 (ML-141) did not alter PAR2-induced wound healing (p>0.05). In contrast, Rac1 inhibition by NSC23766 completely abrogated the PAR2-induced wound healing (p<0.05). Conclusion(s) PAR2 activation drives wound healing via Src tyrosine kinase and Rac1 activities. These findings provide a further mechanism whereby PAR2 can participate in the resolution of intestinal wounds in gastrointestinal inflammatory diseases. Disclosure of Interest None Declared

Protease-activated receptor-2 activation enhances epithelial wound healing via epidermal growth factor receptor

A6 PROTEASE-ACTIVATED RECEPTOR (PAR)-2 ACTIVATION ENHANCES EPITHELIAL WOUND HEALING MIGRATION THROUGH SRC AND RAC1 PATHWAYS

Protease-activated receptor 2 drives migration in a colon cancer cell line but not in noncancerous human epithelial cells

A Gαq-Ca2+ Signaling Pathway Promotes Actin-Mediated Epidermal Wound Closure in C. Elegans

Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice

Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes

Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2

PAR2 Deficiency Enhances Myeloid Cell-Mediated Immunosuppression and Promotes Colitis-Associated Tumorigenesis.

Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model

Mice expressing fluorescent PAR2 reveal that endocytosis mediates colonic inflammation and pain

PAR-2 Promotes Invasion and Migration of Esophageal Cancer Cells by Activating MEK/ERK and PI3K/Akt Signaling Pathway

Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF

Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro

Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2

Effects of Mast Cells Induced by NSAIDs Impair Intestinal Epithelial Barrier Function In Vivo and In Vitro

Pathophysiological function of proteinase activated receptor 2 in skin

NANOPARTICLE ENCAPSULATION OF THE SPECIALIZED PRO-RESOLVING MEDIATOR MARESIN-2: A NOVEL APPROACH FOR PROMOTING MUCOSAL REPAIR IN THE INTESTINE

Activation of Erk in ileal epithelial cells engaged in ischemic-injury repair

Wound healing of intestinal epithelial cells

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

Prostaglandin E2 receptor PTGER4-expressing macrophages promote intestinal epithelial barrier regeneration upon inflammation